vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and COMMVAULT SYSTEMS INC (CVLT). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $311.7M, roughly 1.6× COMMVAULT SYSTEMS INC). COMMVAULT SYSTEMS INC runs the higher net margin — 4.7% vs -10.1%, a 14.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 13.3%). COMMVAULT SYSTEMS INC produced more free cash flow last quarter ($131.8M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 17.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Commvault Systems, Inc. is an American publicly traded cybersecurity and data protection software company. Commvault's services are used for data security, as well as cloud and infrastructure management.

CLOV vs CVLT — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.6× larger
CLOV
$487.7M
$311.7M
CVLT
Growing faster (revenue YoY)
CLOV
CLOV
+31.4% gap
CLOV
44.7%
13.3%
CVLT
Higher net margin
CVLT
CVLT
14.8% more per $
CVLT
4.7%
-10.1%
CLOV
More free cash flow
CVLT
CVLT
$200.8M more FCF
CVLT
$131.8M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
17.8%
CVLT

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
CLOV
CLOV
CVLT
CVLT
Revenue
$487.7M
$311.7M
Net Profit
$-49.3M
$14.6M
Gross Margin
81.4%
Operating Margin
-10.1%
5.3%
Net Margin
-10.1%
4.7%
Revenue YoY
44.7%
13.3%
Net Profit YoY
-123.2%
EPS (diluted)
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
CVLT
CVLT
Q1 26
$311.7M
Q4 25
$487.7M
$313.8M
Q3 25
$496.6M
$276.2M
Q2 25
$477.6M
$282.0M
Q1 25
$462.3M
$275.0M
Q4 24
$337.0M
$262.6M
Q3 24
$331.0M
$233.3M
Q2 24
$356.3M
$224.7M
Net Profit
CLOV
CLOV
CVLT
CVLT
Q1 26
$14.6M
Q4 25
$-49.3M
$17.8M
Q3 25
$-24.4M
$14.7M
Q2 25
$-10.6M
$23.5M
Q1 25
$-1.3M
$31.0M
Q4 24
$-22.1M
$11.0M
Q3 24
$-9.2M
$15.6M
Q2 24
$7.4M
$18.5M
Gross Margin
CLOV
CLOV
CVLT
CVLT
Q1 26
81.4%
Q4 25
81.1%
Q3 25
80.1%
Q2 25
82.0%
Q1 25
82.6%
Q4 24
81.5%
Q3 24
24.5%
81.6%
Q2 24
30.3%
82.3%
Operating Margin
CLOV
CLOV
CVLT
CVLT
Q1 26
5.3%
Q4 25
-10.1%
6.3%
Q3 25
-4.9%
4.5%
Q2 25
-2.2%
8.9%
Q1 25
-0.3%
9.7%
Q4 24
-6.4%
5.2%
Q3 24
-2.7%
6.4%
Q2 24
2.0%
8.2%
Net Margin
CLOV
CLOV
CVLT
CVLT
Q1 26
4.7%
Q4 25
-10.1%
5.7%
Q3 25
-4.9%
5.3%
Q2 25
-2.2%
8.3%
Q1 25
-0.3%
11.3%
Q4 24
-6.6%
4.2%
Q3 24
-2.8%
6.7%
Q2 24
2.1%
8.2%
EPS (diluted)
CLOV
CLOV
CVLT
CVLT
Q1 26
$0.34
Q4 25
$0.40
Q3 25
$0.33
Q2 25
$0.52
Q1 25
$0.68
Q4 24
$0.24
Q3 24
$0.35
Q2 24
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
CVLT
CVLT
Cash + ST InvestmentsLiquidity on hand
$78.3M
$900.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$7.5M
Total Assets
$541.0M
$1.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
CVLT
CVLT
Q1 26
$900.0M
Q4 25
$78.3M
$1.0B
Q3 25
$1.1B
Q2 25
$363.2M
Q1 25
$302.1M
Q4 24
$194.5M
$243.6M
Q3 24
$288.0M
$303.1M
Q2 24
$254.8M
$287.9M
Stockholders' Equity
CLOV
CLOV
CVLT
CVLT
Q1 26
$7.5M
Q4 25
$308.7M
$216.7M
Q3 25
$340.9M
$210.5M
Q2 25
$344.2M
$364.7M
Q1 25
$336.1M
$325.1M
Q4 24
$341.1M
$287.8M
Q3 24
$342.2M
$277.8M
Q2 24
$324.9M
$281.8M
Total Assets
CLOV
CLOV
CVLT
CVLT
Q1 26
$1.9B
Q4 25
$541.0M
$2.0B
Q3 25
$559.7M
$1.9B
Q2 25
$575.0M
$1.2B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.0B
Q3 24
$653.0M
$958.5M
Q2 24
$674.2M
$934.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
CVLT
CVLT
Operating Cash FlowLast quarter
$-66.9M
$132.2M
Free Cash FlowOCF − Capex
$-69.0M
$131.8M
FCF MarginFCF / Revenue
-14.1%
42.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
9.02×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$237.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
CVLT
CVLT
Q1 26
$132.2M
Q4 25
$-66.9M
$4.0M
Q3 25
$12.1M
$76.8M
Q2 25
$5.4M
$31.7M
Q1 25
$-16.3M
$77.0M
Q4 24
$34.8M
$30.1M
Q3 24
$50.0M
$55.6M
Q2 24
$44.8M
$44.7M
Free Cash Flow
CLOV
CLOV
CVLT
CVLT
Q1 26
$131.8M
Q4 25
$-69.0M
$1.9M
Q3 25
$11.4M
$73.6M
Q2 25
$4.8M
$29.8M
Q1 25
$-16.5M
$76.2M
Q4 24
$33.3M
$29.9M
Q3 24
$49.6M
$53.7M
Q2 24
$44.4M
$43.8M
FCF Margin
CLOV
CLOV
CVLT
CVLT
Q1 26
42.3%
Q4 25
-14.1%
0.6%
Q3 25
2.3%
26.6%
Q2 25
1.0%
10.6%
Q1 25
-3.6%
27.7%
Q4 24
9.9%
11.4%
Q3 24
15.0%
23.0%
Q2 24
12.5%
19.5%
Capex Intensity
CLOV
CLOV
CVLT
CVLT
Q1 26
Q4 25
0.4%
0.7%
Q3 25
0.1%
1.2%
Q2 25
0.1%
0.7%
Q1 25
0.0%
0.3%
Q4 24
0.5%
0.1%
Q3 24
0.1%
0.8%
Q2 24
0.1%
0.4%
Cash Conversion
CLOV
CLOV
CVLT
CVLT
Q1 26
9.02×
Q4 25
0.23×
Q3 25
5.21×
Q2 25
1.35×
Q1 25
2.48×
Q4 24
2.74×
Q3 24
3.57×
Q2 24
6.04×
2.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

CVLT
CVLT

Term-based license$114.4M37%
Software-as-a-service$93.1M30%
Customer support$80.9M26%
Other$13.1M4%
Perpetual license$10.1M3%

Related Comparisons